Displaying 1 - 10 of 1779
People who buy coverage individually through the marketplace will be negatively impacted by new regulations proposed by the Trump Administration, which would promote plans with higher deductibles and cost-sharing and plans with no networks,…
Families USA, on behalf of the Consumers First steering committee, submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed Transparency in Coverage (TiC) rule. Consumers First seeks to ensure the nation’s health…
Families USA submitted comment on the Centers for Medicare & Medicaid Services (CMS) model GUARD (Guarding U.S. Medicare Against Rising Drug Costs). Families USA supports the broader efforts to test new payment approaches to…
The Trump Administration’s Latest Attack on Medically Necessary, Gender- Affirming Care The Trump administration is continuing its attacks on access to health care for transgender Americans, this time by cutting off Medicare and Medicaid…
Families USA submitted comments on the Centers for Medicare & Medicaid Services (CMS) proposed rule Medicare and Medicaid Programs; Hospital Conditions of Participation: Limiting Participation Based on the Performance of Sex Trait Modification Procedures…
President Trump and HHS Secretary Kennedy are reshaping America’s public health infrastructure by taking unprecedented steps to alter the childhood vaccine schedule — changes driven by ideology rather than scientific evidence. These actions have…
On February 10th, 2026, Families USA submitted written testimony to the New York State Joint Legislative Budget Hearing on Health, expressing support for the Fair Pricing Act (S. 705/A. 2140). The Fair Pricing Act would ensure that…
Families USA submitted a statement on the Energy and Commerce Health Subcommittee outlining how big drug companies and Pharmacy Benefit Managers (PBM) are driving up the cost of prescription drugs. Our statement recommends Congress…
The Medicare Advantage (MA) program — now covering more than 33 million older adults — was created to deliver higher-quality, more coordinated care at a lower cost. Yet unchecked corporate profiteering within the program…
For decades, policymakers talked about lowering prescription drug prices — in 2022, Congress actually did something about it by passing the Inflation Reduction Act which gave Medicare, for the first time, the power to directly negotiate with drug…